DACH1 and lung carcinoma: In a study of lung cancers based on whole-genome sequencing, DACH1 emerged as a biologically significant target of mutation (loss-of-function alterations in particular) [35], and its homozygous deletion has been reported in some glioblastoma multiformes [36].